According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2015, only 67% of adults living with HIV in Malawi were receiving life-saving antiretroviral therapy (ART). In Malawi, 84,000 children, under the age of 15, are living with HIV. Approximately 58,000 HIV-positive women give birth annually, and without any intervention an estimated 17,400 infants will be born with HIV each year.
Download Country Fact Sheet

Key Program Accomplishments

Since 2001, EGPAF-Malawi has:

Averted nearly 12,000 HIV infections

Currently supports over 85,000 individuals on antiretroviral therapy (ART)

Provided PMTCT services to more than 1,220,000 women

Ensured nearly 61,000 pregnant women received antiretroviral prophylaxis

Our Work

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) began collaborating with local partners in 2001 to initiate one of Malawi’s first programs to provide prevention of mother-to-child HIV transmission (PMTCT) services. Currently, EGPAF-Malawi provides technical assistance in the provision of adult and pediatric HIV prevention, care and treatment services to more than 130 Malawian Ministry of Health (MOH) and faith-based facilities, district-level health teams, and community-based organizations (CBOs).

EGPAF-Malawi also participates in numerous national technical working groups focused on PMTCT, HIV care and treatment, tuberculosis (TB), human resources for health, sexual and reproductive health, program monitoring and evaluation, and quality assurance. EGPAF continually promotes solutions to reduce the pediatric HIV treatment gap through participation in a pediatric treatment technical working group.

Additionally, EGPAF-Malawi conducts operations research to better understand patient perceptions of HIV programs and increase opportunities to improve early infant HIV diagnosis, and use of PMTCT and HIV care and treatment services. Completed studies have focused on utilizing early infant HIV testing and diagnosis to enhance pediatric care and treatment; the acceptability of Option B+ among HIV-positive pregnant and lactating women and feasibility of its implementation among heath care workers; and on retention of women and children in the entire PMTCT cascade.